본문 바로가기

Wearable ECG patch monitoring for 72 h is comparable to conventional Holter monitoring for 24 h to detect cardiogenic vertigo

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
SCIENTIFIC REPORTS15(1) · 2025
피인용
Web of Science 7Scopus 7
FWCI (Scopus)
1.07
JCR IF
JCR 2024 3.9
ISSN
2045-2322

저자

  1. Kim, Hyun Ah제1저자Keimyung Univ, Sch Med, Dept Neurol, Daegu, South Korea
  2. Lee, HyungKeimyung Univ, Sch Med, Dept Neurol, Daegu, South Korea
  3. Park, Hyoung-SeobKeimyung Univ, Sch Med, Dept Internal Med, Div Cardiol, Daegu, South Korea
  4. 안진희Pusan Natl Univ, Sch Med, Pusan Natl Univ Hosp, Div Cardiol,Dept Internal Med, Daegu, South Korea
  5. 이숙민Pusan Natl Univ, Pusan Natl Univ Hosp, Dept Neurol, Sch Med, 179 Gudeok Ro, Busan 602739, South Korea
  6. 최서영Pusan Natl Univ, Pusan Natl Univ Hosp, Dept Neurol, Sch Med, 179 Gudeok Ro, Busan 602739, South Korea
  7. 오은혜Pusan Natl Univ, Pusan Natl Univ Hosp, Dept Neurol, Sch Med, 179 Gudeok Ro, Busan 602739, South Korea
  8. 최재환Pusan Natl Univ, Pusan Natl Univ Hosp, Dept Neurol, Sch Med, 179 Gudeok Ro, Busan 602739, South Korea
  9. Park, Ji-YunUniv Ulsan, Coll Med, Dept Neurol, Ulsan, South Korea
  10. 최광동교신저자Pusan Natl Univ, Pusan Natl Univ Hosp, Dept Neurol, Sch Med, 179 Gudeok Ro, Busan 602739, South Korea

초록

We sought to compare the diagnostic efficacy of a 72-hour wearable electrocardiography (ECG) patch monitoring with a conventional 24-hour Holter monitoring for the detection of cardiogenic vertigo. We conducted a prospective multicenter study that recruited 47 patients suspected of cardiogenic vertigo in four referral-based university hospitals between November 2019 and April 2022. Patients received simultaneous ambulatory ECG recordings using a 72-hour wearable ECG patch monitoring and a conventional 24-hour Holter monitor. The primary outcome was the detection rate of arrhythmia events during the entire wearing period. The secondary outcomes included device preference and factors affecting the detection of cardiogenic vertigo. During the 72-hour monitoring period, there was no significant difference in the overall detection rate of arrhythmia events between the wearable patch and conventional Holter monitoring (10 of 47 [21.3%] vs. 8 of 47 [17.0%], p =.500) Most patients (46/47) favored a wearable patch over Holter monitoring. The effectiveness of wearable ECG patch monitoring was comparable to conventional Holter monitoring in detecting cardiogenic vertigo. With its extended monitoring capability and patient preference, wearable patch monitoring holds promise as an alternative method for the diagnosis of cardiogenic vertigo. Limitations of this study include small sample size and selection bias.

키워드

SYNCOPEMANAGEMENTPATIENT

식별자

Scopus EID
2-s2.0-86000044273
WoS UID
001486621500030